伊芙美尔医疗 ICCC 深 沪
等待开盘 03-26 09:30:00 美东时间
6.44
+0.050
+0.78%
华盛通- 最 高6.44
- 今 开6.355
- 成交量 1962股
- 最 低 6.355
- 昨 收 6.39
- 总市值 5825.53万
- 52周最高 7.60
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 4.52
- 委 比 83.33%
- 总股本 904.59万
- 历史最高 13.20
- 量 比 0.19
- 振 幅 1.33%
- 历史最低 3.19
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
ImmuCell Corporation announced the appointment of Kathy Turner to its Board of Directors, effective April 1, 2026, replacing Steven Rosgen, who is retiring after 8 years of service. Turner, with over three decades of leadership experience in global healthcare and animal health markets, will serve as Chair of the Compensation and Stock Option Committee and a member of the Audit Committee. Her experience includes roles at Elanco Animal Health, IDEX...
03-18 20:05
ImmuCell Q4 EPS $(0.31) Down From $0.06 YoY, Sales $7.626M Down From $7.751M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.31) per share. This is a 616.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $7.626 million in sales this
03-05 05:08
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
ImmuCell Corporation reported a net operating income of $1.6 million for 2025, up $3.3 million from 2024, driven by higher volumes, manufacturing efficiencies, and price realization. Product sales rose 4.3% to $27.6 million, and gross margin improved to 41.4%. Despite a $1.0 million net loss, the company highlighted successful commercial outreach, increased manufacturing output, and a new strategy focusing on the First Defense® franchise. Cash an...
03-04 21:05
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
ImmuCell Corporation Updates Financial Calendar
ImmuCell Corporation Updates Financial Calendar - **Unaudited financial results release (Q4 and full-year 2025):** ImmuCell Corporation (Nasdaq: ICCC) will report its unaudited financial results **after the market closes on Wednesday, March 4, 2026**. - **Results conference call:** ImmuCell will hos
02-18 21:37
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
ImmuCell Corporation will release unaudited financial results for Q4 and FY 2025 on March 4, 2026, after market close. A conference call to discuss the results is scheduled for March 5, 2026, at 9:00 AM ET, accessible via (844) 855-9502 (toll-free) or (412) 317-5499 (international). A replay will be available until March 12, 2026, at (855) 669-9658 (toll-free) or (412) 317-0088 (international) using code 2017737. The Company expects no changes to...
02-18 13:37
ImmuCell Directors Rosgen and Gathagan to Step Down in 2026
ImmuCell Directors Rosgen and Gathagan to Step Down in 2026 ImmuCell Corporation announced that directors Steven A. Rosgen and Bryan K. Gathagan have decided not to seek re-election at the 2026 Annual Meeting of Shareholders, citing time constraints due to their full-time leadership roles elsewhere.
02-10 05:08
ImmuCell kündigt Rückzug von zwei Vorstandsmitgliedern bis 2026 an
ImmuCell kündigt Rückzug von zwei Vorstandsmitgliedern bis 2026 an ImmuCell Corporation hat bekanntgegeben, dass die Direktoren Steven A. Rosgen und Bryan K. Gathagan nicht für eine Wiederwahl auf der Hauptversammlung 2026 zur Verfügung stehen werden. Beide begründen ihre Entscheidung mit Zeitbeschr
02-10 05:07
ImmuCell Sets New Executive Pay Packages and Performance Incentives
ImmuCell Sets New Executive Pay Packages and Performance Incentives ImmuCell Corporation has announced new employment agreements for key executives, effective January 27, 2026. Chief Financial Officer Timothy C. Fiori will receive an annual base salary of $315,000, while Senior Vice President of Sal
02-03 06:23
ImmuCell Corporation beschließt neue Vergütungsvereinbarungen für Führungskräfte
ImmuCell Corporation beschließt neue Vergütungsvereinbarungen für Führungskräfte ImmuCell Corporation hat neue Vergütungsvereinbarungen für CFO Timothy C. Fiori und Senior Vice President Bobbi Jo Brockmann bekannt gegeben. Ab dem 27. Januar 2026 erhalten Fiori ein Jahresgrundgehalt von 315.000 US-Do
02-03 06:23
